title: New topical medications in the treatment of glaucoma.
abstract: 1. Latanoprost is not preferred for use in inflammatory glaucoma. 2. Brimonidine acts by reducing the aqueous inflow and promotes uveoscleral outflow. 3. Dorzolamide causes a moderate reduction of intraocular pressure, but is relatively safe.
authors.affiliation: Lions Eye Institute, Albany Medical College, NY 12208, USA.
authors.forename: S B
authors.initials: SB
authors.lastname: Gandham
mesh_terms: D000287:Administration, Topical; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D000068438:Brimonidine Tartrate; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D000077338:Latanoprost; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage*; D011810:Quinoxalines / Q000008:administration & dosage*; D013449:Sulfonamides / Q000008:administration & dosage*; D013876:Thiophenes / Q000008:administration & dosage*
chemical_list: D000959:Antihypertensive Agents; D011461:Prostaglandins F, Synthetic; D011810:Quinoxalines; D013449:Sulfonamides; D013876:Thiophenes; D000068438:Brimonidine Tartrate; D000077338:Latanoprost; C062765:dorzolamide